期刊文献+

N-cadherin和vimentin在直肠腺癌中的表达及其临床意义 被引量:5

The expression of N-cadherin and vimentin in rectum adenocarcinoma and their clinical value
下载PDF
导出
摘要 目的探讨N钙黏蛋白(neuronal cadherin,N-cadherin)和波形蛋白(vimentin)在原发性直肠腺癌中的表达及其临床意义。方法选择手术切除并经病理证实的58例原发性直肠腺癌组织和距肿瘤5cm以上的正常直肠黏膜组织,采用免疫组织化学SP法检测组织中N-cadherin和vimentin的表达并与临床资料进行相关性分析。结果直肠腺癌组织中N-cadherin和vimentin阳性表达率[53.4%(31/58)、46.6%(27/58)]明显高于正常直肠黏膜组织[3.4%(2/58)、1.7%(1/58)](P<0.01);N-cadherin和vimentin的阳性率与肿瘤浸润深度、淋巴结转移、远处转移和TNM分期呈正相关(P<0.05),与肿瘤分化程度无相关性(P>0.05)。结论 N-cadherin和vimentin的表达与原发性直肠腺癌的转移密切相关,检测N-cadherin和vimentin的表达可作为判断直肠腺癌转移和预后的指标之一。 Objective To observe the expression of neuronal cadherin (N-cadherin) and vimentin in primary rectum adenocarci-noma tissues and their clinical value .Methods 58 cases of primary rectum adenocarcinoma tissues after surgical resection and con-firmed by pathology ,and normal rectum tissues that at lest 5 cm away from the tumor were selected .The immunohistochemical SP method was used to detect the expression of N-cadherin and vimentin and analyzed their correlation .Results In rectum adenocarci-noma tissues ,the positive expression rate of N-cadherin and vimentin[53 .4% (31/58) ,46 .6% (27/58)]were significantly higher than those of in normal rectum mucosa tissues[3 .4% (2/58) ,1 .7% (1/58)] ,(P&lt;0 .01) .The expressions of N-cadherin and vimen-tin were positively correlated with the depth of cancer invasion ,lymph node metastasis ,distant metastasis and tumor-node-metasta-sis(TNM) stage(P&lt;0 .05) ,but without correlated with the tumor cell differentiation(P&gt;0 .05) .Conclusion N-cadherin and vim-entin have close relationships with metastasis of rectum adenocarcinoma ,to detect the expressions of N-cadherin and vimentin is of a effective method to judge the metastasis and prognosis of rectum adenocarcinoma .
作者 张俊君 郭轶
出处 《重庆医学》 CAS CSCD 北大核心 2014年第8期935-936,940,共3页 Chongqing medicine
关键词 黏蛋白类 波形蛋白 直肠肿瘤 腺癌 肿瘤转移 mucins vimentin rectum neoplasms adenocarcinoma neoplasms metastasis
  • 相关文献

参考文献16

  • 1Jemal A,Siegel R, Ward E,et al. Cancer statistics, 2009 [J]. CA Cancer J Clin, 2009,59 (4) : 225-249.
  • 2万德森,陈功.结直肠癌的流行病学及其危险因素研究近况[J].实用癌症杂志,2000,15(2):220-222. 被引量:103
  • 3Huerta S. Critical concepts in the oncogenesis of adenocarcionoma of the rectum[J]. Crit Rev Oncog, 2012; 17 (4) :323-329.
  • 4Nguyen PT ,Kudo Y, Yoshida M,et al. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition [J]. Histol Histopathol, 2011 , 26 (2) : 147-156.
  • 5Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy[J]. Cell Mol Life Sci, 2011,68(18) :3033-3046.
  • 6Tong LL,Gao PvWang ZN,et al. Is the seventh edition of the UICC/ AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? [J]. Ann Surg,2012,255(2) :208-213.
  • 7Edwards BK,Ward E,Kohler BA,et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates [J]. Cancer,2010 .116(3): 544-573.
  • 8Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges[J]. Nat Med, 2006,12(8) :895-904.
  • 9Christiansen JJ , Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis[J]. Cancer Res, 2006,66(17) : 8319- 8326.
  • 10Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic[J]. Biochim Biophys Acta,2009,1796(2) :75-90.

二级参考文献6

共引文献102

同被引文献38

  • 1刘霞,董丽娟,贺继东,王谦,张军鹏.miRNA-767-3p在结直肠癌中的表达与患者临床病理特征及预后的关系[J].热带医学杂志,2019(6):735-738. 被引量:6
  • 2蒋益兰,潘敏求,蔡美.健脾消癌饮配合化疗拮抗大肠癌术后复发转移62例总结[J].湖南中医杂志,2007,23(1):1-3. 被引量:55
  • 3Thiery JP.Epithelial-mesenchymal transitions in tumour progression[J].Nat Rev Cancer,2002 ,2(6):442-454.
  • 4Voulgari A,Pintzas A.Epithelial-mesenchymal transition in cancer metastasis : mechanisms, markers and strategies to overcome drug resistance in the clinic[J].Biochim Bio- phys Acta,2009,1796(2):75-90.
  • 5Landis SH, Murray T, Bolden S,et al.Cancer statistics,1999[J].CA Cancer J Clin,1999 ,49(1):8-31.
  • 6Tanaka T,Makita H,Kawabata K,et al.1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopre- ventive activity in rat tongue carcinogenesis[J].Cancer Res,1997,57(17):3644-3648.
  • 7Sakaki T5Tamura LKadota H,et al.Changing expression of E- and P-cadherin during rat tongue carcinogenesis in- duced by 4-nitroquinoline l-oxide[J].J Oral Pathol Med, 2003,32(9):530-537.
  • 8Lang SH,Hyde C,Reid IN, et al.Enhanced expression of vimentin in motile prostate cell lines and in poorly differ- entiated and metastatic prostate carcinoma[J].Prostate, 2002,52(4):253-263.
  • 9Singh S,Sadacharan S,Su S,et al, Overexpression of vim- entin: role in the invasive phenotype in an androgen-inde- pendent model of prostate cancer[J], Cancer Res,2003 ,63(9):2306-2311.
  • 10Paccione RJ, Miyazaki H,Patel V,et al, Keratin down- regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility[J].Mol Cancer Ther,2008,7(9):2894-2903.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部